EXActDNA-003: Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated with Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease NSABP B-64

Brief Summary

Type:
Other

Study Type:
Other

Phase:
N/A

ClinicalTrials.gov Identifier:
NCT06401421

Study #:
STUDY00161483

Start Date:
Jul 25, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06401421

View Complete Trial Details & Eligibility at ClinicalTrials.gov